Although funds have not been appropriated for the peer-reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP), the office recently sent notification to the research community of recently released pre-announcements http://cdmrp.army.mil/pubs/press/press.shtml) to allow investigators time to plan and develop ideas for submission to the anticipated FY18 funding opportunities.
FY18 funding opportunities are anticipated for the following programs:
- Amyotrophic Lateral Sclerosis Research Program
- Bone Marrow Failure Research Program
- Breast Cancer Research Program
- Multiple Sclerosis Research Program
- Ovarian Cancer Research Program
- Peer-Reviewed Medical Research Program
Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement. FY18 pre-announcements can be found in the CDMRP homepage features at http://cdmrp.army.mil.
Ready To Take the Next Step?
We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.